BC Cancer - Surrey

13750 96th Avenue
Surrey, BC, V3V 1Z2

Clinical Trial Unit Manager
Nicole Valade
604-319-8067
nicole.valade@bccancer.bc.ca

Hematology

A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide with or without Pomalidomide in Patients with Relapsed and Refractory Multiple Myeloma

Cancer Type
Hematology
Phase II
Recruiting Dates
BC Cancer - Surrey
Open Recruiting Date
View on ClinicalTrials.gov
Back to top